Atrophic vaginitis refers to thinning and dryness of the vaginal and vulval tissues caused mainly by low estrogen after menopause. The newer term GSM is broader, but many women still hear the older name in clinic. In India, it is common, under-recognised, and often hidden behind vague complaints like irritation, painful sex, or urinary burning.

Roughly half of postmenopausal women develop meaningful symptoms over time, including many Indian women who never bring it up unless asked directly. Cultural discomfort around discussing sex after menopause makes the condition seem rarer than it is. A sensitive OB consultation, sometimes with a female clinician if preferred, often opens the conversation.

After menopause, estrogen levels fall sharply. The vaginal lining becomes thinner, natural lubrication drops, elasticity reduces, and the tissues become more fragile. Vaginal pH also rises, which changes the local protective environment and makes irritation and infection-like symptoms more likely.

The same process can happen earlier in women who have had both ovaries removed, chemotherapy, pelvic radiation, or medicines that suppress estrogen. This is why GSM is not only an age issue. It is fundamentally an estrogen-deficiency issue affecting the vulva, vagina, lower urinary tract, and nearby tissues.

Common symptoms are vaginal dryness, burning, itching, soreness, and pain with sex. Some women describe a rubbing or tearing sensation during penetration, followed by light spotting after sex because the tissue is more fragile. Others mainly feel daily discomfort while walking, sitting, or passing urine.

Urinary symptoms are also common and easily missed. These include recurrent UTIs, urgency, burning without a clear infection, urethral discomfort, and the feeling of passing urine too often. When the vaginal exam looks dry and thin and urine cultures are repeatedly mixed or negative, GSM should be considered.

Genitourinary syndrome of menopause is the modern term because it captures more than vaginal dryness alone. It includes vulval symptoms, vaginal symptoms, sexual pain, and urinary complaints together. That matters because many women present first with bladder symptoms rather than with dryness.

Using the term GSM also helps explain the full pelvic estrogen-deficiency picture. The vagina, vulva, urethra, and bladder neck all respond to estrogen. When estrogen falls, the problem is often shared across these structures, so treatment needs to address the whole symptom pattern rather than one isolated complaint.

For mild GSM, non-hormonal vaginal moisturisers are a reasonable first step. They are used regularly, not only during sex, and can reduce dryness and irritation. Replens and similar products in India usually cost about Rs. 500 to Rs. 1,500 depending on pack size and pharmacy.

Lubricants are for sexual activity, not long-term tissue treatment. Water-based or silicone-based options can make penetration much more comfortable. Common Indian options include KY Jelly at about Rs. 150 to Rs. 400, Astroglide at about Rs. 400 to Rs. 800, and Sirona Intimate gels around Rs. 250 to Rs. 500.

Low-dose vaginal estrogen is the gold standard for moderate to severe GSM when moisturisers are not enough. It directly treats the tissue problem by improving thickness, elasticity, lubrication, and local pH. In India, options may include estrogen creams such as Premarin cream at about Rs. 400 to Rs. 1,200, vaginal tablets such as Vagifem, and rings such as Estring where available.

This is not the same as oral hormone therapy. Vaginal estrogen used in low doses for local symptoms has very low systemic absorption, especially compared with tablets taken by mouth. For women whose symptoms are mainly vaginal or urinary, it is usually a safer and more targeted option than oral HRT.

Most postmenopausal women with GSM can use low-dose vaginal estrogen, especially when symptoms are affecting comfort, sleep, intimacy, or urinary health. Because absorption is minimal, many women who should avoid systemic hormone therapy can still be candidates for local treatment after an individual review.

Even some breast cancer survivors may be able to use vaginal estrogen after clearance from their oncology and OB teams, particularly when symptoms are severe and non-hormonal measures fail. Recent warning-label discussions, including FDA black-box language, are increasingly being re-examined because local vaginal dosing behaves very differently from oral hormone therapy.

Regular gentle sexual activity or masturbation can help maintain blood flow, tissue stretch, and comfort over time. The phrase many specialists use is simple: use it or lose it. This should never be forced through pain, but with lubricant or treatment support it can help maintain vaginal flexibility.

Pelvic floor exercises, good hydration, breathable cotton underwear, and gentle cleansing with plain water or bland cleansers support daily comfort. Women who feel shy discussing sexual symptoms can still ask for help in terms of burning, dryness, or urine discomfort. Many Indian hospitals such as Apollo, Cloudnine, and Fortis offer menopause consultations, often around Rs. 800 to Rs. 2,000.

Avoid perfumed soaps, vaginal douches, fragranced wipes, and harsh laundry detergents on underwear. These products can worsen burning and disrupt already fragile tissue. Strong antiseptic washes are not a treatment for GSM and often make symptoms worse.

Tight synthetic underwear and very tight leggings can increase friction and heat. Smoking also worsens GSM because it further reduces blood flow and is associated with poorer estrogen-related tissue health. If a product stings on application, stop using it and reassess rather than pushing through.

See an OB or menopause specialist if dryness, burning, painful sex, or urinary symptoms are affecting quality of life. Recurrent UTIs, repeated urgency, and sex-related pain are all valid reasons for treatment. Many women wait too long because they assume this is just normal ageing, but effective treatment is available.

Postmenopausal bleeding must be taken seriously and cancer should be ruled out first, even if bleeding seems to happen only after sex. Relationship strain, avoidance of intimacy, or persistent fear of pain are also good reasons to seek care. In some areas, ASHA workers may direct women to PHC menopause clinics where counselling is free or low-cost.